Stavros Nicolaou is a seasoned and well experienced pharmaceutical executive, with 33 years’ experience mainly in domestic and international general management and strategy.

He is a member of Aspen Pharmacare Holdings Limited Group Executive Committee and is the Group Senior Executive responsible for Strategic Trade Development. Previously Stavros was CEO of Aspen’s Export Business. He was instrumental in introducing the first generic ARV’s on the African Continent developed by Aspen, which has gone on to save hundreds of thousands of lives in South Africa and on the African Continent.

Stavros has been Recognized in the Global Top 100 Health Edition Honorees Most Influential People of African Descent (MIPAD) in Healthcare. He is a previous winner of the South African Institute of Marketing Management (IMM) Health Care Marketer of the year Award, and he has been inducted as a fellow of the Pharmaceutical Society of South Africa. Stavros has been elected as an honorary member of the Southern African Society for Thrombosis and Haemostasis and has received an honorary doctorate in Medicine from Wits University.